Literature DB >> 31440945

Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007.

Svenja Boekhoff1, Brigitte Bison2, Maria Eveslage3, Panjarat Sowithayasakul4, Hermann L Müller5.   

Abstract

PURPOSE: Childhood-onset craniopharyngiomas (CP) are diagnosed due to clinical symptoms (symCP) or incidentally (incCP). We investigated clinical manifestations and outcome in incCPs and symCPs.
METHODS: IncCP were discovered in 4 (3 m/1 f) and symCP in 214 (101 m/113 f) CP recruited 2007-2014 in KRANIOPHARYNGEOM 2007. Age, sex, height, body mass index (BMI), tumor volume, degree of resection, pre- and postsurgical hypothalamic involvement/lesions, pituitary function and outcome were compared between both subgroups.
RESULTS: Reasons for imaging in incCP were cerebral palsy, head trauma, nasal obstruction, and tethered-cord syndrome, whereas headache (44%), visual impairment (25%), and growth retardation (17%) lead to imaging in symCP. Tumor volume at diagnosis was smaller in incCP (median 2.39 cm3; range 0.14-4.10 cm3) when compared with symCP (15.86 cm3; 0.002-286.34 cm3). Age, gender, BMI, height, hydrocephalus, tumor location, and hypothalamic involvement at diagnosis of incCP were within the range of these parameters in symCP. Complete resections were achieved more frequently (3/4 patients) in incCP when compared with symCP (20%). Surgical hypothalamic lesions were distributed similar in incCP and symCP. Irradiation was performed only in symCP (33%). No noticeable differences were observed concerning survival rates, endocrine deficiencies, BMI, height, functional capacity and quality of life of the 4 incCP cases when compared with the symCP cohort.
CONCLUSIONS: IncCP are rare (1.8%) and characterized by lack of endocrine deficiencies, resulting in normal height and BMI, no hydrocephalus, and smaller tumor volume at diagnosis when compared with symCPs. Outcome of the observed incCP is similar with symCP. CLINICAL TRIAL REGISTRATION NUMBER: NCT01272622.

Entities:  

Keywords:  Craniopharyngioma; Hypothalamus; Incidentaloma; Pituitary; Quality of life

Mesh:

Year:  2019        PMID: 31440945     DOI: 10.1007/s11102-019-00983-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  34 in total

1.  Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence.

Authors:  Hermann L Müller; Ursel Gebhardt; Andreas Faldum; Angela Emser; Nicole Etavard-Gorris; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-05-12       Impact factor: 1.475

2.  Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire.

Authors:  G Calaminus; S Weinspach; C Teske; U Göbel
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

Review 3.  Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

Authors:  N Karavitaki; C Brufani; J T Warner; C B T Adams; P Richards; O Ansorge; B Shine; H E Turner; J A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2005-04       Impact factor: 3.478

4.  Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.

Authors:  H L Müller; K Bueb; U Bartels; C Roth; K Harz; N Graf; R Korinthenberg; M Bettendorf; J Kühl; P Gutjahr; N Sörensen; G Calaminus
Journal:  Klin Padiatr       Date:  2001 Jul-Aug       Impact factor: 1.349

5.  Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000.

Authors:  H L Müller; U Gebhardt; N Etavard-Gorris; E Korenke; M Warmuth-Metz; R Kolb; N Sörensen; G Calaminus
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

6.  Differential diagnosis of suprasellar tumors in children.

Authors:  M Warmuth-Metz; A K Gnekow; H Müller; L Solymosi
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

Review 7.  Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.

Authors:  Stéphanie Puget; Matthew Garnett; Alison Wray; Jacques Grill; Jean-Louis Habrand; Nathalie Bodaert; Michel Zerah; Mercia Bezerra; Dominique Renier; Alain Pierre-Kahn; Christian Sainte-Rose
Journal:  J Neurosurg       Date:  2007-01       Impact factor: 5.115

8.  [Clinical symptoms in 35 children and adolescents with craniopharyngeoma at the time of diagnosis].

Authors:  T Rohrer; K Gassmann; M Buchfelder; D Wenzel; R Fahlbusch; H G Dörr
Journal:  Klin Padiatr       Date:  2002 Sep-Oct       Impact factor: 1.349

9.  Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.

Authors:  Hermann L Müller; Angela Emser; Andreas Faldum; Gina Bruhnken; Nicole Etavard-Gorris; Ursel Gebhardt; Rudolf Oeverink; Reinhard Kolb; Niels Sörensen
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 10.  Craniopharyngiomas.

Authors:  Niki Karavitaki; Simon Cudlip; Christopher B T Adams; John A H Wass
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

View more
  3 in total

Review 1.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

Review 2.  The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?

Authors:  Thomas Cuny; Michael Buchfelder; Henry Dufour; Ashley Grossman; Blandine Gatta-Cherifi; Emmanuel Jouanneau; Gerald Raverot; Alexandre Vasiljevic; Frederic Castinetti
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575

Review 3.  Application of Artificial Intelligence in Diagnosis of Craniopharyngioma.

Authors:  Caijie Qin; Wenxing Hu; Xinsheng Wang; Xibo Ma
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.